A 52 Week Open Label Trial of Memantine for Frontotemporal Lobar Degeneration

NCT00187525 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Frontotemporal Lobar Degeneration

Interventions

DRUG: Memantine

Sponsor

University of California, San Francisco

Collaborators

[object Object]